Cargando…
Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer
Purpose: Death anxiety is commonly experienced by individuals with advanced cancer who have a limited life expectancy. The Death and Dying Distress Scale (DADDS) is a validated measure that was created to capture this experience; but no Chinese version is available to date. We conducted a cross-sect...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564352/ https://www.ncbi.nlm.nih.gov/pubmed/34744816 http://dx.doi.org/10.3389/fpsyt.2021.715756 |
_version_ | 1784593599735791616 |
---|---|
author | Tang, Lili Zhang, Yening Pang, Ying Zhou, Yuhe Li, Jinjiang Song, Lili He, Yi Li, Zimeng Wang, Yan |
author_facet | Tang, Lili Zhang, Yening Pang, Ying Zhou, Yuhe Li, Jinjiang Song, Lili He, Yi Li, Zimeng Wang, Yan |
author_sort | Tang, Lili |
collection | PubMed |
description | Purpose: Death anxiety is commonly experienced by individuals with advanced cancer who have a limited life expectancy. The Death and Dying Distress Scale (DADDS) is a validated measure that was created to capture this experience; but no Chinese version is available to date. We conducted a cross-sectional study to explore the psychometric properties of a Chinese version DADDS (DADDS-C) and address prevalence of death anxiety among patients with advanced cancer. Methods: Patients with advanced cancer were recruited from Peking University Cancer Hospital. Measures administered included: DADDS-C, Patient Health Questionnaire (PHQ-9), General Anxiety Disorder-7(GAD-7), Quality of Life at End of Life in Cancer (QUAL-EC), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-sp). McDonald's Omega, Cronbach's alpha, Exploratory Factor Analysis and Confirmatory Factor Analysis were used to test DADDS-C's reliability and validity. Logistic regression analysis was used to identify risk factors for death anxiety. Results: Of 300 patients approached, 256 (85%) provided informed consent and completed the questionnaires. Of these participants, 43 (16.8%) had moderate death anxiety based on scores of ≥45 on the DADDS-C. Three factors (feeling shortness of time, dying and death distress, being a burden to others) explained 71.643% of shared variation with factor loadings ranging from 0.629 to 0.822. Cronbach's alpha was 0.939; Omega total was 0.959. DADDS-C had acceptable convergent and discriminant validity. Logistic regression analysis indicated that two factors (better relationship with healthcare providers and preparation for end of life) protected patients from death anxiety. Conclusion: DADDS-C is a valid tool for measuring death anxiety in Chinese patients with advanced cancer. The presence of at least moderate death anxiety in a substantial minority of these patients calls for screening for this symptom and for more routine psychological interventions to alleviate and prevent such distress in this population. |
format | Online Article Text |
id | pubmed-8564352 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85643522021-11-04 Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer Tang, Lili Zhang, Yening Pang, Ying Zhou, Yuhe Li, Jinjiang Song, Lili He, Yi Li, Zimeng Wang, Yan Front Psychiatry Psychiatry Purpose: Death anxiety is commonly experienced by individuals with advanced cancer who have a limited life expectancy. The Death and Dying Distress Scale (DADDS) is a validated measure that was created to capture this experience; but no Chinese version is available to date. We conducted a cross-sectional study to explore the psychometric properties of a Chinese version DADDS (DADDS-C) and address prevalence of death anxiety among patients with advanced cancer. Methods: Patients with advanced cancer were recruited from Peking University Cancer Hospital. Measures administered included: DADDS-C, Patient Health Questionnaire (PHQ-9), General Anxiety Disorder-7(GAD-7), Quality of Life at End of Life in Cancer (QUAL-EC), Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-sp). McDonald's Omega, Cronbach's alpha, Exploratory Factor Analysis and Confirmatory Factor Analysis were used to test DADDS-C's reliability and validity. Logistic regression analysis was used to identify risk factors for death anxiety. Results: Of 300 patients approached, 256 (85%) provided informed consent and completed the questionnaires. Of these participants, 43 (16.8%) had moderate death anxiety based on scores of ≥45 on the DADDS-C. Three factors (feeling shortness of time, dying and death distress, being a burden to others) explained 71.643% of shared variation with factor loadings ranging from 0.629 to 0.822. Cronbach's alpha was 0.939; Omega total was 0.959. DADDS-C had acceptable convergent and discriminant validity. Logistic regression analysis indicated that two factors (better relationship with healthcare providers and preparation for end of life) protected patients from death anxiety. Conclusion: DADDS-C is a valid tool for measuring death anxiety in Chinese patients with advanced cancer. The presence of at least moderate death anxiety in a substantial minority of these patients calls for screening for this symptom and for more routine psychological interventions to alleviate and prevent such distress in this population. Frontiers Media S.A. 2021-10-20 /pmc/articles/PMC8564352/ /pubmed/34744816 http://dx.doi.org/10.3389/fpsyt.2021.715756 Text en Copyright © 2021 Tang, Zhang, Pang, Zhou, Li, Song, He, Li and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Tang, Lili Zhang, Yening Pang, Ying Zhou, Yuhe Li, Jinjiang Song, Lili He, Yi Li, Zimeng Wang, Yan Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title | Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title_full | Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title_fullStr | Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title_full_unstemmed | Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title_short | Validation of Death and Dying Distress Scale-Chinese Version and Prevalence of Death Anxiety Among Patients With Advanced Cancer |
title_sort | validation of death and dying distress scale-chinese version and prevalence of death anxiety among patients with advanced cancer |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564352/ https://www.ncbi.nlm.nih.gov/pubmed/34744816 http://dx.doi.org/10.3389/fpsyt.2021.715756 |
work_keys_str_mv | AT tanglili validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT zhangyening validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT pangying validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT zhouyuhe validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT lijinjiang validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT songlili validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT heyi validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT lizimeng validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer AT wangyan validationofdeathanddyingdistressscalechineseversionandprevalenceofdeathanxietyamongpatientswithadvancedcancer |